James Eaton is a Maywood, Illinois based neurologist who is specialized in Neurology. Active license number of James Eaton is 125.084406 for Neurology in Illinois. His current practice location is 2160 S 1st Ave, Maywood. Patients can reach him at 708-216-2687. James Eaton is DO in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1003666249. James Eaton specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
James Eaton speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
James Eaton
Specialization:
Neurology
Gender:
Male
Credentials:
DO
Practice Address:
2160 S 1st Ave, Maywood, Illinois, 60153-3328
Phone:
708-216-2687
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1003666249
NPI Enumeration Date:
22 Mar, 2024
NPI Last Update On:
25 Jul, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for James Eaton are as mentioned below.
License Number
Specialization
State
Status
125.084406
Neurology
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
James Eaton 2160 S 1st Ave, Maywood, Illinois
Zip:
60153-3328
Patients can reach James Eaton at 2160 S 1st Ave, Maywood, Illinois or can call to book an appointment on 708-216-2687.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.